64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer-Reference-Cited by-同舟云学术

64Cu-DOTA-trastuzumab PET imaging for HER2-specific primary lesions of breast cancer

Published:2017-08 Issue:8 Volume:28 Page:2028-2029
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Sasada S.,Kurihara H.,Kinoshita T.,Yoshida M.,Honda N.,Shimoi T.,Shimomura A.,Yunokawa M.,Yonemori K.,Shimizu C.,Hamada A.,Kanayama Y.,Watanabe Y.,Fujiwara Y.,Tamura K.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/28/8/2028/19388815/mdx227.pdf

Reference5 articles.

1. Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies;Amir;Cancer Treat Rev,2012

2. 64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer;Tamura;J Nucl Med,2013

3. (64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients;Kurihara;EJNMMI Res,2015

4. Functional imaging of human epidermal growth factor receptor 2-positive metastatic breast cancer using (64)Cu-DOTA-trastuzumab PET;Mortimer;J Nucl Med,2014

5. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer, American Society of Clinical Oncology; College of American Pathologists;Wolff;J Clin Oncol,2013

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of HER2-targeted PET/CT imaging in patients with breast cancer and therapeutic response monitoring;The Oncologist;2024-07-31

2. PET/CT and SPECT/CT Imaging of HER2-Positive Breast Cancer;Journal of Clinical Medicine;2023-07-25

3. Development and evaluation of [64Cu]Cu-DOTATATE for clinical applications;IRAN J NUCL MED;2023

4. Molecular and functional imaging in cancer-targeted therapy: current applications and future directions;Signal Transduction and Targeted Therapy;2023-02-27

5. Novel HER2-Targeted Peptide for NIR-II Imaging of Tumor;Molecular Pharmaceutics;2023-01-20